Effect of sotalol on heart rate variability assessed by Holter monitoring in patients with ventricular arrhythmias

This publication has 20 references indexed in Scilit:

• Frequency domain measures of heart period variability and mortality after myocardial infarction.
  Circulation, 1992
• Mortality and Morbidity in Patients Receiving Encainide, Flecainide, or Placebo
  New England Journal of Medicine, 1991
• Heart rate variability in patients with ventricular arrhythmias: Effect of antiarrhythmic drugs
  Journal of the American College of Cardiology, 1991
• Effect of atenolol and diltiazem on heart period variability in normal persons
  Journal of the American College of Cardiology, 1991
• CAST and beyond. Implications of the Cardiac Arrhythmia Suppression Trial. Task Force of the Working Group on Arrhythmias of the European Society of Cardiology.
  Circulation, 1990
• The independence of cycle length variability and exercise testing on predicting mortality of patients surviving acute myocardial infarction
  The American Journal of Cardiology, 1990
• Sotalol: A beta blocker with unique antiarrhythmic properties
  American Heart Journal, 1987
• Decreased heart rate variability and its association with increased mortality after acute myocardial infarction
  The American Journal of Cardiology, 1987
• New method for assessing cardiac parasympathetic activity using 24 hour electrocardiograms.
  Heart, 1984
• Sudden cardiac death: The major challenge confronting contemporary cardiology
  The American Journal of Cardiology, 1979